Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Am J Ophthalmol. 2014 Apr 29;158(1):64–70.e2. doi: 10.1016/j.ajo.2014.04.007

Figure 2.

Figure 2

Assessment of rose bengal vs. riboflavin photodynamic therapy for the inhibition of Fusarium solani keratitis isolates. (Top), (Bottom). Results shown at Day 0 and Day 3. Maximum confluency is seen at Day 3 with only the rose bengal-mediated PDT group (Group 5) showing growth inhibition. (First Column) Group 1, (Second Column) Group 2, (Third Column) Group 3, (Fourth Column) Group 4, (Fifth Column) Group 5.